40
Views
8
CrossRef citations to date
0
Altmetric
CASE REPORT

A case of Muckle–Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin)

, , , , , , & show all
Pages 496-499 | Received 26 Mar 2007, Accepted 04 Jun 2007, Published online: 02 Jan 2014

References

  • Ozen S, Hoffman HM, Frenkel J, Kastner D. Familial Mediterra-nean fever (FMF) and beyond: a new horizon. Fourth international congress on the systemic autoinflammatory diseases held in Bethesda, USA, 6-10 November 2005. Ann Rheum Dis 2006; 65:961–4.
  • Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 1962;31:235–48.
  • Kubota T, Koike R. Biological and clinical aspects of Muckle-Wells syndrome (in Japanese). Jpn J Clin Immunol 2007;30:114–22.
  • INFEVERS Homepage. Available from: http://fmf.igh.cnrs.fr/ ISSAID/infevers/index.php.
  • Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003;4:95–104.
  • Martinon F,Tschopp J. NLRs join TLRs as innate sensors of patho-gens. Trends Immunol 2005;26:447–54.
  • Homepage of Ministry of education, culture, sports, science and technology. Available from: http://www.mext.go.jp/bmenu/houdou/ 18/10/06100304/003/002.pdf.
  • Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301–5.
  • Hawkins PN, Lachmann HJ. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348:2583–4.
  • Hawkins PN, Lachmann HJ, Aganna E, McDermott ME Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607–12.
  • Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M, Queyrel V, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum 2006;54: 1697–700.
  • Rynne M, Maclean C, Bybee A, McDermott MF, Emery P. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Ann Rheum Dis 2006;65: 533–4.
  • Feldmann J, Prieur A-M, Quartier P, Berquin P, Certain S, Cortis E, et al. Chronic infantile neurological cutaneous and articular syn-drome is caused by mutations in CIASI, a gene highly expressed in polymorphonucear cells and chondrocytes. Am J Hum Genet 2002;71:198–203.
  • Matsubayashi T, Sugiura H, Arai T, Oh-Ishi T, Inamo Y Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIASI gene. Acta Paediatr 2006;95:246–9.
  • Matsubara T, Hasegawa M, Shiraishi M, Hoffman HM, Ichiyama T, Tanaka T, et al. A severe case of chronic infantile neurologic, cuta-neous, articular syndrome treated with biologic agents. Arthritis Rheum 2006;54:2314–20.
  • Saito M, Fujisawa A, Nishikomori R, Kambe N, Nakata-Hizume M, Yoshimoto M, et al. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2005;52: 3579–85.
  • Kagami S, Saeki H, Kuwano Y, Imakado S, Tamaki K. A probable case of Muckle-Wells syndrome. J Dermatol 2006;2:118–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.